title: [Possibilities and limits of chemotherapy in multi-modality treatment of urinary bladder cancer].
authors.forename: U
authors.initials: U
authors.lastname: Rüther
authors.forename: J
authors.initials: J
authors.lastname: Rassweiler
authors.forename: M
authors.initials: M
authors.lastname: Lüthgens
authors.forename: P
authors.initials: P
authors.lastname: Bub
authors.forename: P
authors.initials: P
authors.lastname: Jipp
authors.forename: F
authors.initials: F
authors.lastname: Eisenberger
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D015251:Epirubicin; D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate
vernacular_title: Möglichkeiten und Grenzen der Chemotherapie bei der multimodalen Therapie des Harnblasenkarzinoms.